The classification of PD-L1 in HCC is complex, and the level of spatial and cellular heterogeneity is high, which may affect the reliability and repeatability of PD-L1 as a predictor of response to treatment with ICIs in comparison to other markers (15). The gene discussed is CD274; the disease is hepatocellular carcinoma.